1.82
price down icon2.67%   -0.05
pre-market  Vorhandelsmarkt:  1.82  
loading

Actinium Pharmaceuticals Inc Aktie (ATNM) Neueste Nachrichten

pulisher
Jul 24, 2025

What institutions are buying Actinium Pharmaceuticals Inc. stock nowFree Wealth Management Insights - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What drives Actinium Pharmaceuticals Inc. stock priceRecord-breaking gains - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Actinium Pharmaceuticals Inc. stock outlookUnbelievable profit margins - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Is Actinium Pharmaceuticals Inc. a good long term investmentFree Stock Market Beginners Guide - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Actinium Pharmaceuticals Inc. Stock Analysis and ForecastHigh-performance investment picks - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Actinium Pharmaceuticals Inc. stockMarket-crushing stock picks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Actinium Pharmaceuticals Inc. stock attracts strong analyst attentionCapital Protected Stock Selections - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

Lead Plaintiff Appointed in Actinium Pharmaceuticals Class Action - TradingView

Jul 21, 2025
pulisher
Jul 17, 2025

Is Actinium Pharmaceuticals Inc. stock a growth or value playFree Access to Investment Community - beatles.ru

Jul 17, 2025
pulisher
Jul 15, 2025

How Actinium Pharmaceuticals Inc. stock performs during market volatilityRisk Managed Trading Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Actinium Pharmaceuticals Inc. stock price move sharplyFree Investment Group - Newser

Jul 15, 2025
pulisher
Jul 02, 2025

Actinium Highlights ATNM 400 Progress at SNMMI Conference - ca.finance.yahoo.com

Jul 02, 2025
pulisher
Jun 30, 2025

Actinium’s ATNM-400 demonstrates superior efficacy in prostate cancer - BioWorld MedTech

Jun 30, 2025
pulisher
Jun 23, 2025

Innovative Prostate Cancer Treatment ATNM-400 Shows Promising Pr - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

Actinium Highlights Expanded Data Set for ATNM-400 in Prostate Cancer Demonstrating Superior Efficacy to Enzalutamide and Ability to Overcome Resistance to ARPI Therapy and PSMA-Ac-225/Lu-177 Labelled Radiotherapy at the Society of Nuclear Medic - PR Newswire

Jun 23, 2025
pulisher
Jun 19, 2025

Investigation announced for Long-Term Investors in shares - openPR.com

Jun 19, 2025
pulisher
Jun 13, 2025

Millennium Management LLC Has $148,000 Stake in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World

Jun 13, 2025
pulisher
Jun 10, 2025

Kuehn Law Encourages Investors of Actinium Pharmaceuticals, Inc. to Contact Law Firm - PR Newswire

Jun 10, 2025
pulisher
Jun 08, 2025

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Shares Acquired by Squarepoint Ops LLC - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Nuveen Asset Management LLC Increases Stock Holdings in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) Seeking Recovery for InvestorsContact The Gross Law Firm - mx.advfn.com

Jun 06, 2025
pulisher
Jun 06, 2025

ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Actinium Pharmaceuticals, Inc. to Contact the Firm Today! - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 03, 2025

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Shares Purchased by Deutsche Bank AG - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Northern Trust Corp Grows Stock Holdings in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World

Jun 02, 2025
pulisher
May 28, 2025

Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM)May 27, 2025 Deadline to JoinContact Levi & Korsinsky - PR Newswire

May 28, 2025
pulisher
May 27, 2025

Shareholders of Actinium Pharmaceuticals, Inc. (ATNM): Protect Your Rights Before May 27, 2025Contact Levi & Korsinsky - ACCESS Newswire

May 27, 2025
pulisher
May 27, 2025

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - Business Wire

May 27, 2025
pulisher
May 26, 2025

ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

May 26, 2025
pulisher
May 26, 2025

FINAL REMINDER ATNM DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Actinium Pharmaceuticals, Inc. Investors to Participate in the Class Action Lawsuit - ACCESS Newswire

May 26, 2025
pulisher
May 26, 2025

2025-05-26 | Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Urged to Join Class Action Before May 27, 2025Contact Levi & Korsinsky | NYSEAM:ATNM | Press Release - Stockhouse

May 26, 2025
pulisher
May 26, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming DeadlinesATNM - Eastern Progress

May 26, 2025
pulisher
May 26, 2025

ATNM Deadline: ATNM Investors with Losses in Excess of $100K Hav - GuruFocus

May 26, 2025
pulisher
May 26, 2025

ATNM Deadline: ATNM Investors with Losses in Excess of $100K Have Opportunity to Lead Actinium Pharmaceuticals, Inc. Securities Fraud Lawsuit - Morningstar

May 26, 2025
pulisher
May 26, 2025

Class Action Lawsuit Filed: Actinium Pharmaceuticals, Inc. (ATNM)Join by May 27, 2025Contact Levi & Korsinsky - Stockhouse

May 26, 2025
pulisher
May 26, 2025

Press releases provided by CNW - Techaeris

May 26, 2025
pulisher
May 25, 2025

Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Contact Levi & Korsinsky to Join Class Action Before May 27, 2025 - ACCESS Newswire

May 25, 2025
pulisher
May 25, 2025

ATNM DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Actinium Pharmaceuticals, ... - Eagle-Tribune

May 25, 2025
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Kapitalisierung:     |  Volumen (24h):